Skip Navigation

An open label, randomized, phase II study to assess the effectiveness of RCHOP with previously untreated indolent non-Hodgkin's lymphomas

An open label, randomized, phase II study to assess the effectiveness of RCHOP with previously untreated indolent non-Hodgkin's lymphomas
Year2010
Sponsor(s)Millennium Pharmaceuticals
Institution(s)Emory University
Principal Investigator(s)Chris Flowers, MD
Project website ยป
Health Systems Institute
Search eBIRT